Your browser doesn't support javascript.
loading
Private variants in PRKN are associated with late-onset Parkinson's disease.
Hopfner, Franziska; Mueller, Stefanie H; Szymczak, Silke; Junge, Olaf; Tittmann, Lukas; May, Sandra; Lohmann, Katja; Grallert, Harald; Lieb, Wolfgang; Strauch, Konstantin; Müller-Nurasyid, Martina; Berger, Klaus; Schormair, Barbara; Winkelmann, Juliane; Mollenhauer, Brit; Trenkwalder, Claudia; Maetzler, Walter; Berg, Daniela; Kasten, Meike; Klein, Christine; Höglinger, Günter U; Gasser, Thomas; Deuschl, Günther; Franke, André; Krawczak, Michael; Dempfle, Astrid; Kuhlenbäumer, Gregor.
Afiliação
  • Hopfner F; Department of Neurology, Universitätsklinikum Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany; Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Mueller SH; Department of Neurology, UKSH, Christian-Albrechts-University, Kiel, Germany; Institute of Health Informatics, University College London, London, UK.
  • Szymczak S; Institute of Medical Informatics and Statistics, Kiel University, University Hospital Schleswig-Holstein, 24105, Kiel, Germany.
  • Junge O; Institute of Medical Informatics and Statistics, Kiel University, University Hospital Schleswig-Holstein, 24105, Kiel, Germany.
  • Tittmann L; Institute of Epidemiology, University of Kiel, Germany.
  • May S; Institute of Clinical Molecular Biology, Kiel University, University Hospital Schleswig-Holstein, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.
  • Lohmann K; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
  • Grallert H; Institute of Epidemiology II, German Research Center for Environmental Health, Helmholtz Zentrum München, Neuherberg, Germany; Research Unit of Molecular Epidemiology, German Research Center for Environmental Health, Helmholtz Zentrum München, Neuherberg, Germany; German Center for Diabetes Research
  • Lieb W; Institute of Epidemiology, University of Kiel, Germany.
  • Strauch K; Institute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany; Chair of Genetic Epidemiology, Institute of Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-University, Munich, Germany.
  • Müller-Nurasyid M; Institute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, 85764, Germany; Department of Medicine I, Ludwig-Maximilians-Universität, Munich, 80539, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alli
  • Berger K; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
  • Schormair B; Institute of Neurogenomics, Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany.
  • Winkelmann J; Institute of Neurogenomics, Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Ingolstädter Landstr. 1, 85764, Neuherberg, Germany; Institut für Humangenetik, Klinikum rechts der Isar, Fakultät für Medizin, Technische Universität München, Ismaninger Straße 22, 81675, Mü
  • Mollenhauer B; Paracelsus-Elena-Klinik Kassel, Kassel, Germany; Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
  • Trenkwalder C; Department Neurosurgery, University Medical Center, Goettingen, Germany; Paracelsus-Elena Hospital, Kassel, Germany.
  • Maetzler W; Department of Neurology, UKSH, Christian-Albrechts-University, Kiel, Germany.
  • Berg D; Department of Neurology, UKSH, Christian-Albrechts-University, Kiel, Germany.
  • Kasten M; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany; Department of Psychiatry and Psychotherapy, University of Lübeck, Germany.
  • Klein C; Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
  • Höglinger GU; Technical University of Munich, School of Medicine, Department of Neurology, Munich, Germany; German Center for Neurodegenerative Diseases, Munich, Germany; Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Gasser T; Hertie Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, University Clinic Tuebingen, Tuebingen, Germany.
  • Deuschl G; Department of Neurology, UKSH, Christian-Albrechts-University, Kiel, Germany.
  • Franke A; Institute of Clinical Molecular Biology, Kiel University, University Hospital Schleswig-Holstein, Campus Kiel, Rosalind-Franklin-Straße 12, 24105, Kiel, Germany.
  • Krawczak M; Institute of Medical Informatics and Statistics, Kiel University, University Hospital Schleswig-Holstein, 24105, Kiel, Germany.
  • Dempfle A; Institute of Medical Informatics and Statistics, Kiel University, University Hospital Schleswig-Holstein, 24105, Kiel, Germany.
  • Kuhlenbäumer G; Department of Neurology, UKSH, Christian-Albrechts-University, Kiel, Germany. Electronic address: Gregor.Kuhlenbaeumer@uksh.de.
Parkinsonism Relat Disord ; 75: 24-26, 2020 06.
Article em En | MEDLINE | ID: mdl-32442813
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Ubiquitina-Proteína Ligases Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Parkinsonism Relat Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Ubiquitina-Proteína Ligases Tipo de estudo: Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Parkinsonism Relat Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido